Dr Sarah Ryan’s research aims to understand the role of brain’s immune cells, microglia, in frontotemporal dementia, and whether addressing brain inflammation could be a new therapeutic target.
The Bruton's tyrosine kinase inhibitor tolebrutinib is reportedly the first agent to show benefit in patients with nonrelapsing secondary progressive MS.
Microglia are the brain's immune cells known ... the blood coagulation protein fibrin causes the unusual clotting and inflammation that have become hallmarks of the disease, while also suppressing ...
Microglia regulate inflammation, synaptic plasticity, and the formation of neural networks, all of which affect depression.” A few years ago, I read The Angel and The Assassin by Donna Jackson ...